An Ontology-based Approach to Guide and Document Variable and Data Source Selection and Data Integration Process to Support Integrative Data Analysis in Cancer Outcomes Research
暂无分享,去创建一个
[1] Robert B Hines,et al. Disparities in Late Stage Diagnosis, Treatment, and Breast Cancer-Related Death by Race, Age, and Rural Residence Among Women in Georgia , 2012, Women & health.
[2] Patrick B. Ryan,et al. Transparent Reporting of Data Quality in Distributed Data Networks , 2015, EGEMS.
[3] Paolo Vineis,et al. STrengthening the Reporting of OBservational studies in Epidemiology - Molecular Epidemiology (STROBE-ME): an extension of the STROBE statement. , 2011, Preventive medicine.
[4] Gailen D. Marshall,et al. Minimum data elements for research reports on CFS , 2012, Brain, Behavior, and Immunity.
[5] Aditya Ghose,et al. The effect of imputing missing clinical attribute values on training lung cancer survival prediction model performance , 2017, Health Inf. Sci. Syst..
[6] Yi Guo,et al. The relationships among individual and regional smoking, socioeconomic status, and oral and pharyngeal cancer survival: a mediation analysis , 2015, Cancer medicine.
[7] Dennis L. Jackson. Reporting results of latent growth modeling and multilevel modeling analyses: some recommendations for rehabilitation psychology. , 2010, Rehabilitation psychology.
[8] Robert Arp,et al. Building Ontologies with Basic Formal Ontology , 2015 .
[9] David Atkins,et al. Good research practices for comparative effectiveness research: defining, reporting and interpreting nonrandomized studies of treatment effects using secondary data sources: the ISPOR Good Research Practices for Retrospective Database Analysis Task Force Report--Part I. , 2009, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[10] Paolo Vineis,et al. STrengthening the Reporting of OBservational studies in Epidemiology--Molecular Epidemiology (STROBE-ME): an extension of the STROBE statement. , 2011, Mutagenesis.
[11] W. Dixon,et al. Launch of a checklist for reporting longitudinal observational drug studies in rheumatology: a EULAR extension of STROBE guidelines based on experience from biologics registries , 2013, Annals of the rheumatic diseases.
[12] G. Xing,et al. Comorbidities and mammography use interact to explain racial/ethnic disparities in breast cancer stage at diagnosis , 2011, Cancer.
[13] L. Mobley,et al. Demographic Disparities in Late-Stage Diagnosis of Breast and Colorectal Cancers Across the USA , 2016, Journal of Racial and Ethnic Health Disparities.
[14] Yi Guo,et al. An ontology-guided semantic data integration framework to support integrative data analysis of cancer survival , 2018, BMC Medical Informatics and Decision Making.
[15] S. Madhi,et al. Strengthening the Reporting of Observational Studies in Epidemiology for Newborn Infection (STROBE-NI): an extension of the STROBE statement for neonatal infection research. , 2016, The Lancet. Infectious diseases.
[16] J. Ioannidis,et al. Strengthening the reporting of Genetic RIsk Prediction Studies: the GRIPS Statement. , 2011, Journal of clinical epidemiology.
[17] Manolis Tsiknakis,et al. The INTEGRATE project: Delivering solutions for efficient multi-centric clinical research and trials , 2016, J. Biomed. Informatics.
[18] V. Feigin,et al. Development of the standards of reporting of neurological disorders (STROND) checklist: a guideline for the reporting of incidence and prevalence studies in neuroepidemiology , 2015, European Journal of Epidemiology.
[19] P. Horby,et al. CONSISE statement on the reporting of Seroepidemiologic Studies for influenza (ROSES‐I statement): an extension of the STROBE statement , 2016, Influenza and other respiratory viruses.
[20] Olaf Klungel,et al. The reporting of studies conducted using observational routinely collected health data statement for pharmacoepidemiology (RECORD-PE) , 2018, British Medical Journal.
[21] N. Dubrawsky. Cancer statistics , 1989, CA: a cancer journal for clinicians.
[22] S G E Marsh,et al. A community standard for immunogenomic data reporting and analysis: proposal for a STrengthening the REporting of Immunogenomic Studies statement. , 2011, Tissue antigens.
[23] E. Mulvey,et al. Reporting guidance for violence risk assessment predictive validity studies: the RAGEE Statement. , 2015, Law and human behavior.
[24] Trish Groves,et al. Enhancing the quality and transparency of health research , 2008, BMJ : British Medical Journal.
[25] Kathleen F Kerr,et al. RiGoR: reporting guidelines to address common sources of bias in risk model development , 2015, Biomarker Research.
[26] L. Leibovici,et al. STROBE-AMS: recommendations to optimise reporting of epidemiological studies on antimicrobial resistance and informing improvement in antimicrobial stewardship , 2016, BMJ Open.
[27] Laura H. Kahn,et al. Checklist for One Health Epidemiological Reporting of Evidence (COHERE) , 2017, One health.
[28] Gary S Collins,et al. Transparent Reporting of a Multivariable Prediction Model for Individual Prognosis or Diagnosis (TRIPOD): The TRIPOD Statement. , 2015, European urology.
[29] Csongor Nyulas,et al. BioPortal: enhanced functionality via new Web services from the National Center for Biomedical Ontology to access and use ontologies in software applications , 2011, Nucleic Acids Res..
[30] S. Pocock,et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. , 2008, Journal of clinical epidemiology.
[31] David Moher,et al. The REporting of Studies Conducted Using Observational Routinely-Collected Health Data (RECORD) Statement: Methods for Arriving at Consensus and Developing Reporting Guidelines , 2015, PloS one.
[32] S. Glaser,et al. The influence of nativity and neighborhoods on breast cancer stage at diagnosis and survival among California Hispanic women , 2010, BMC Cancer.
[33] E. Forsum,et al. Strengthening the Reporting of Observational Studies in Epidemiology—Nutritional Epidemiology (STROBE-nut): An Extension of the STROBE Statement , 2016, PLoS medicine.
[34] Klaus R. Dittrich,et al. Data Provenance: A Categorization of Existing Approaches , 2007, BTW.
[35] Jiang Bian,et al. Assessing the effect of data integration on predictive ability of cancer survival models , 2020, Health Informatics J..
[36] Shiraz I Mishra,et al. Breast cancer epidemiology in blacks and whites: disparities in incidence, mortality, survival rates and histology. , 2008, Journal of the National Medical Association.
[37] P. Eke,et al. Standards for reporting chronic periodontitis prevalence and severity in epidemiologic studies: Proposed standards from the Joint EU/USA Periodontal Epidemiology Working Group. , 2015, Journal of clinical periodontology.
[38] Patrick D Schloss,et al. Identifying and Overcoming Threats to Reproducibility, Replicability, Robustness, and Generalizability in Microbiome Research , 2018, mBio.
[39] Etienne G. Krug,et al. Violence: a global public health problem , 2006 .
[40] L. Borrell,et al. A Local Area Analysis of Racial, Ethnic, and Neighborhood Disparities in Breast Cancer Staging , 2009, Cancer Epidemiology, Biomarkers & Prevention.
[41] Matthew J. Salganik,et al. Strengthening the Reporting of Observational Studies in Epidemiology for respondent-driven sampling studies: “STROBE-RDS” statement , 2015, Journal of clinical epidemiology.
[42] N. Keating,et al. Racial differences in breast cancer stage at diagnosis in the mammography era. , 2013, American journal of public health.
[43] Jiang Bian,et al. Ontology for Documentation of Variable and Data Source Selection Process to Support Integrative Data Analysis in Cancer Outcomes Research , 2019, SEPDA@ISWC.
[44] I. Wilson,et al. ESPACOMP Medication Adherence Reporting Guideline (EMERGE) , 2018, Annals of Internal Medicine.
[45] T. Vos,et al. Guidelines for Accurate and Transparent Health Estimates Reporting: the GATHER statement , 2016, PLoS medicine.
[46] A. Silman,et al. Preliminary core set of domains and reporting requirements for longitudinal observational studies in rheumatology. , 1999, The Journal of rheumatology.
[47] M. Follen,et al. Nativity disparities in late-stage diagnosis and cause-specific survival among Hispanic women with invasive cervical cancer: an analysis of Surveillance, Epidemiology, and End Results data , 2013, Cancer Causes & Control.